Navigation Links
David Barker, Former Illumina CSO, Joins GenVault's Scientific Advisory Board
Date:9/28/2007

CARLSBAD, Calif., Sept. 28 /PRNewswire/ -- GenVault Corporation today announces that industry expert David Barker Ph.D. has joined its Scientific Advisory Board. In his role on the board, Dr. Barker will provide scientific guidance facilitating GenVault's entry into new biosample management markets. Dr. Barker brings more than 20 years experience in life science product commercialization as well as experience in serving on the boards of companies such as NextBio, Cell Biosciences, and Microchip Biotechnologies.

"Dr. Barker's extraordinarily deep understanding of the industry and its future will be extremely valuable as we chart our vision. We are very honored to welcome Dr. Barker as a key member of the GenVault advisory team," said David Wellis, CEO of GenVault

"Well-characterized biological samples and their intelligent storage and retrieval are essential for discovering disease genes and biomarkers. I am pleased to be asked to participate in GenVault's creative solutions for sample management " said Dr. Barker

Dr. Barker's previous product commercialization experience includes senior positions at Illumina as Vice President and Chief Scientific Officer; Amersham Biosciences as Vice President and Chief Science Advisor and Molecular Dynamics as Vice President of Research and Business Development until its acquisition by Amersham Biosciences. In his academic career, Dr. Barker conducted interdisciplinary research in neurobiology as a postdoctoral fellow at Harvard Medical School, Assistant Professor at the University of Oregon and Associate Professor at Oregon State University. Dr. Barker holds a BS with honors in Chemistry from the California Institute of Technology and a PhD in Biochemistry from Brandeis University.

About GenVault

GenVault is redefining the global standard in biosample workflow and storage solutions for genomic medicine, discovery and identification. The company's room temperature technology reduces costs and empowers its partners to maximize their most valuable assets. As a scalable and reliable alternative to traditional freezers and DNA purification systems, GenVault's dry-state platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. For more information visit us at http://www.genvault.com.

EDITORIAL CONTACTS:

David Wellis, GenVault

(760) 268-5256

dwellis@genvault.com


'/>"/>
SOURCE GenVault Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. David Brooks: Segmented nation looks for solidarity amid IT-powered niches
3. CIO Leadership Series: Rick Davidson, Manpower
4. CIO Leadership Series: David Melbye, Milwaukee Metro Sewerage District
5. CIO Leadership Series: David Cagigal, Alliant Energy
6. Former Fiserv exec to enter Business Hall of Fame
7. UW scientist, former WiCell director found stem cell company
8. Kyron appoints former AMA chairman to board
9. Genzyme sues former Bone Care employees
10. Former astronaut a leader in Wisconsin Spaceport
11. New book from former CDC CEO walks readers through innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2017)... ... 15, 2017 , ... Cybrexa Therapeutics, a start-up cancer therapeutics ... in the amount of $6 million. An investment vehicle affiliated with HighCape Partners, ... The Series B funding will enable Cybrexa to complete the build-out of its ...
(Date:6/15/2017)... ... 15, 2017 , ... DuPont Industrial Biosciences (DuPont) announced that ... Bloomberg’s 2017 Sustainable Business Summit: Seattle this Thursday, June 15, at ... a panel titled “Developing a Corporate Renewables Strategy.” , “Consumers want to ...
(Date:6/14/2017)... ... June 14, 2017 , ... The Thailand Board of ... that they’re co-hosting a delegation from Thailand at BIO 2017 in San Diego, ... gathering in the world, regroups more than 1,100 biotech companies, academic institutions, state ...
(Date:6/14/2017)... CA (PRWEB) , ... June 14, 2017 , ... ... cancer diagnostics and personalized medicine technology, today announced four new distribution agreements for ... over the cancer care cycle. The commercial agreements will make ClearID available immediately ...
Breaking Biology Technology:
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
Breaking Biology News(10 mins):